MY154882A - Bioactive extract having blood anticoagulant activity - Google Patents

Bioactive extract having blood anticoagulant activity

Info

Publication number
MY154882A
MY154882A MYPI20082449A MYPI20082449A MY154882A MY 154882 A MY154882 A MY 154882A MY PI20082449 A MYPI20082449 A MY PI20082449A MY PI20082449 A MYPI20082449 A MY PI20082449A MY 154882 A MY154882 A MY 154882A
Authority
MY
Malaysia
Prior art keywords
anticoagulant activity
extract
blood anticoagulant
bioactive extract
clotting time
Prior art date
Application number
MYPI20082449A
Inventor
Muhajir Hamid
Janna Ong Abdullah
Sieo Chin Chin
Eusni Rahayu Mohd Tohit
Zainina Seman
Caroline A P Manicam
Original Assignee
Univ Putra Malaysia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Putra Malaysia filed Critical Univ Putra Malaysia
Priority to MYPI20082449A priority Critical patent/MY154882A/en
Publication of MY154882A publication Critical patent/MY154882A/en

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)

Abstract

THE PRESENT INVENTION RELATES TO THE ANTICOAGULANT ACTIVITY OF THE CRUDE AQUEOUS EXTRACT OF MELASTOMA MALABATHRICUM LINN. ON NORMAL HUMAN BLOOD. CONSEQUENTLY, THIS EXTRACT CAN BE DEVELOPED INTO AN ORAL ANTICOAGULANT DRUG FOR HUMAN CONSUMPTION. ANTICOAGULANT ACTIVITY OF THIS EXTRACT IS EVALUATED IN TERMS OF PROLONGATION OF CLOTTING TIME IN SECONDS IN COMPARISON TO NORMAL HUMAN BLOOD CLOTTING TIME AS WELL AS WITH COMMERCIALLY AVAILABLE ORAL ANTICOAGULANT DRUG, WARFATIN. THE MOST ILLUSTRATIVE
MYPI20082449A 2008-07-03 2008-07-03 Bioactive extract having blood anticoagulant activity MY154882A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MYPI20082449A MY154882A (en) 2008-07-03 2008-07-03 Bioactive extract having blood anticoagulant activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MYPI20082449A MY154882A (en) 2008-07-03 2008-07-03 Bioactive extract having blood anticoagulant activity

Publications (1)

Publication Number Publication Date
MY154882A true MY154882A (en) 2015-08-14

Family

ID=54150098

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20082449A MY154882A (en) 2008-07-03 2008-07-03 Bioactive extract having blood anticoagulant activity

Country Status (1)

Country Link
MY (1) MY154882A (en)

Similar Documents

Publication Publication Date Title
PH12015500407A1 (en) Methods of treating hypertriglyceridemia
IN2012DN02737A (en)
EA201190217A1 (en) SUBSTITUTED 2-ACETAMIDO-5-ARIL-1,2,4-TRIAZOLONES AND THEIR APPLICATION
EA201290078A1 (en) HETEROCYCLIC COMPOUNDS TO INHIBIT PASK
EA201291336A1 (en) SUBSTITUTED 5-FLUOR-1H-PYRAZOLOPIRIDINE AND THEIR APPLICATION
EP2418945A4 (en) Mineral salt-sulfonic acid compositions and methods of use
EA201290267A1 (en) DERIVATIVES OF DIOXABICICLO [3.2.1] OKTAN-2,3,4-TRIOL
WO2010091049A3 (en) Diagnosis and treatment of cancer
WO2009140657A3 (en) Method of treating chronic heart failure
MX2010000266A (en) A method for decreasing symptoms of alcohol consumption.
HUP0800434A2 (en) Template to determine the places of the injections, especially for regular medicament injection and/or blood testing
MX2013001906A (en) Methods of reducing blood lactate concentration.
MX2013011833A (en) Infant formula for use in the prevention of cardiovascular diseases.
WO2013006336A3 (en) Methods and compositions useful for treating fitzpatrick type iv, v or vi skin
MX2010006650A (en) Materials and methods for treatment of pathological ocular vascular proliferation.
WO2011089234A3 (en) Aqueous solution comprising 3 - quinuclidinones for the treatment hyperproliferative, autoimmune and heart disease
WO2012135656A3 (en) Intra-luminal access apparatus and methods of using the same
WO2009136997A3 (en) Inhibitors of human cathepsin l, cathepsin b, and cathepsin s
WO2013025073A3 (en) Composition for preventing or treating diabetes complications containing quamoclit pennata extract
MX2015001508A (en) The use of antithrombin in extracorporeal membrane oxygenation.
MA32416B1 (en) SUBSTITUTED 7-SULFANYLMETHYL-, 7-SULFINYMETHYL-AND 7-SULFONYLMETHYL-INDOLES AND THEIR USE
DK2175877T3 (en) Use of mutated antithrombin for the treatment or prevention of coagulation disorders
WO2012016229A3 (en) Oxytocin treatment to improve memory and modify blood glucose
WO2014026013A3 (en) Methods for maintaining or improving health, well-being and/or a physiological function in a subject
WO2012061811A3 (en) Anti- connective tissue growth factor agent for use in the treatment of lung remodeling disease